Sale is live|00:00:00
ICRA LtdQ3 FY25

ICRA Ltd

Q3 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • ICRA expects continued growth in the Ratings business, driven by focus on high-growth segments like infrastructure and BFSI, with revenue growth of around 13% seen in recent periods.
  • Non-ratings business, especially non-Knowledge Services vertical, is expected to expand, rebalancing the revenue mix towards more diversified, margin-accretive areas.
  • Acquisitions such as Fintellix and D2K are expected to contribute to revenue growth by adding complementary products targeted at the BFSI segment and expanding geographic reach, including the US and Middle East.
  • Fintellix’s shift from license fees to subscription model supports more stable, annuity-style revenues.
  • ICRA aims to leverage AI and technology for operational efficiencies to improve profitability and enable scalable growth.
  • Overall, the company anticipates that inorganic growth through acquisitions and organic scaling will enhance total addressable market and revenues in FY '26 and FY '27 and beyond.

Margin guidance

Category 3
  • Fintellix acquisition expected to provide stable, annuity-like revenues due to shift from license upfront to subscription model, adding to steady future cash flows.
  • Fintellix reported ~20% EBIDA margin, cash-positive business with noncash accelerated depreciation impacting PAT; expected earnings accretive at EBIDA level in initial years.
  • Management anticipates significant value and synergies from Fintellix acquisition, expecting it to be value-accretive, not dilutive, in 2-3 years.
  • Non-ratings business growth to be driven by scaling up of D2K and Fintellix; margins expected to be somewhat lower than Knowledge Services but margin-accretive overall.
  • Continued investments in technology, process reengineering to improve margins, evident over last 7-8 quarters.
  • Organic growth in risk management and market data verticals expected; inorganic growth through acquisitions aligned with expanding product suite and client base.
  • Overall revenue and PAT showed strong H1 growth (Revenue +8.4%, PAT +24.4%), indicating positive momentum going forward.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for ICRA Ltd and 1,400+ other companies.

Fundraise plans

  • There is no explicit mention of any current or planned fundraising through debt or equity in the provided transcript.
  • The discussion focuses on business performance, acquisitions (notably Fintellix), and growth strategies without reference to new capital raising.
  • Regarding financing, there is mention of INR250 crores invested previously (likely in other business areas) which impacts P&L but not future cash.
  • The company does discuss bank credit growth, bond issuances, and market conditions affecting borrowing but not its own fundraising.
  • Therefore, no indication of new equity or debt raising activities is found in this earnings call as of October 29, 2025.

Order book

The transcript provided does not explicitly mention current or expected order book or pending orders for ICRA Limited. However, related insights include: - ICRA Analytics and Fintellix acquisitions are expanding product portfolios and market reach, potentially increasing future orders. - The company is focused on growing non-ratings and non-Moody's businesses, including scaling up risk analytics and regulatory tech offerings. - Domestic consumption and infrastructure lending are expected to remain strong, supporting credit ratings demand. - ICRA foresees growth driven by regulatory changes and product synergies (e.g., with Fintellix in BFSI segment). - There is no direct disclosure on the quantitative size of current order book or pending orders in the excerpt provided. For precise figures on order book or pending orders, refer to detailed financial filings or management disclosures beyond this transcript.

Capex plans

Yes
  • Fintellix shifted its revenue model from upfront license fees to a subscription model about 1-2 years ago, enabling more stable annuity revenues moving forward.
  • Ongoing investments in technology and process reengineering continue to drive efficiencies and margin improvements, particularly in the Ratings business.
  • Some continued investments are planned in D2K to ramp up product development over the next 1 to 1.5 years, driven by increasing market interest.
  • Acquisition of Fintellix included noncash charges such as accelerated depreciation/amortization of prior investments, which will linger for 10-12 months but do not impact cash flow.
  • Strategic focus remains on inorganic growth to scale the Analytics portfolio, including leveraging global presence and unified tech platforms post-Fintellix acquisition.
  • No explicit new capex amounts or timelines were disclosed, but ongoing investment in product and technology capabilities is integral to growth plans.

How does ICRA Ltd rank vs peers in Capital Markets?

Pro feature
1ICRA Ltd
Rev 3Mar 3

See full Capital Markets sector rankings

Unlock with Pro

Want more stocks like ICRA Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio